Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: Toxicities and hematopoietic recovery

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 9-14

  Ballester, O F ^a   Agaliotis, D P ^a   Hiemenz, J W ^a   Janssen, W E ^a   Fields, K K ^a   Zorksy, P E ^a   Goldstein, S C ^a   Perkins, J B ^a   Elfenbein, G J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Autologous; Busulfan and cyclophosphamide; Hematological malignancies; Peripheral blood stem cell transplants

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CANCER SURVIVAL; CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; FEMALE; FEVER; HUMAN; INTERSTITIAL PNEUMONIA; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; NEUTROPENIA; NEUTROPHIL; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE COUNT;

EID: 0029738157     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tutschka PJ, Santos GW, Elfenbein GJ. Marrow transplantation in acute leukemia following busulfan and cyclophosphamide. Blut 1980; 25: 375-380.
2. Santos GW. The development of busulfan/cyclophosphamide preparative regimens. Semin Oncol 1993; 20 (Suppl. 4): 12-16.
3. Copelan EA, Biggs JC, Szer J et al. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BUCY2). Semin Oncol 1993; 20 (Suppl. 4): 33-38.
4. Bensinger WI, Buckner CD, Clift RA et al. Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma. J Clin Oncol 1992; 10: 1492-1497.
5. Armitage JO. Bone marrow transplantation. New Engl J Med 1994; 330: 827-838.
6. Sanz MA, de la Rubia J, San GF et al. Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myelogenous leukemia in first complete remission: a report from a single institution. J Clin Oncol 1993; 11: 1661-1667.
7. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158-3163.
8. Sheridan WP, Begley CG, To LB et al. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 1994; 14: 105-111.
9. Klumpp TR, Mangan KF, Glenn LD et al. Phase II pilot study of high-dose busulfan and CY followed by autologous BM or peripheral stem cell transplantation in patients with advanced chemosensitive breast cancer. Bone Marrow Transplant 1993; 11: 337-339.
10. Schiller G, Nimer S, Vescio R et al. Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma. Bone Marrow Transplant 1994; 14: 131-136.
11. Janssen WE. Peripheral blood and bone marrow hematopoietic stem cells: are they the same? Semin Oncol 1993; 20 (Suppl. 6): 19-27.
12. Fields KK, Zorsky PE, Hiemenz JW et al. Ifosfamide, carboplatin and etoposide: a new regimen with a broad spectrum of activity. J Clin Oncol 1994; 12: 544-552.
13. Ballester OF, Moscinski L, Fields KK et al. Phase I-II trial of DC-IE: a novel intensive induction chemotherapy regimen for multiple myeloma (MM). Blood 1994; 84: 179a (abstr. 703).
14. + cell fraction in bone marrow and blood is not universally predictive of CFU-GM. Exp Hematol 1994; 20: 528-530.
15. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
16. Hiemenz JW, Janssen WE, Fields KK et al. Factors affecting the rate of engraftment following autologous stem cell reinfusion: methods of peripheral blood stem cell mobilization. Exp Hematol 1993; 21: 1164 (Abstr. 566).
17. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.